Lower testosterone levels resulted in higher p-tau concentrations in female APOE4 carriers, suggesting higher testosterone may be inversely related to p-tau levels in AD disease (Sundermann et al., 2020). This evidence concerns the gene MAPT and Alzheimer disease.